Lyka Labs Limited (NSE:LYKALABS)
India flag India · Delayed Price · Currency is INR
57.50
+0.43 (0.75%)
Mar 10, 2026, 11:19 AM IST

Lyka Labs Company Description

Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India.

The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant tablets and combination, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, anti-fungal and bacterial, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products.

It also offers technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data.

The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions.

It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.

Lyka Labs Limited
Country India
Founded 1976
Industry Biotechnology
Sector Healthcare
Employees 499
CEO Kunal Gandhi

Contact Details

Address:
Spencer Building
Mumbai, Gujarat 400036
India
Phone 91 22 6611 2200
Website lykalabs.com

Stock Details

Ticker Symbol LYKALABS
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE933A01014
SIC Code 2834

Key Executives

Name Position
Kunal Narendra Gandhi MD, Chief Executive Officer, Promoter and Director
Yogesh Babulal Shah Chief Financial Officer and Executive Director
Shailendra Kumar Agrawal CS Company Secretary and Compliance Officer